A new blood test combined with a risk model based on the person's history accurately helps determine who is likely to benefit from lung cancer screening, according to a study published today in the i Journal of Clinical Oncology /i led by researchers from The University of Texas MD Anderson Cancer Center.
A personalized lung cancer risk assessment, combining a blood test based on a four-marker protein panel developed at MD Anderson and an independent model (PLCOm2012) that accounts for ...
A new blood test combined with a risk model based on the person's history accurately helps determine who is likely to benefit from lung cancer screening, according to a study published today in the i Journal of Clinical Oncology /i led by researchers from The University of Texas MD Anderson Cancer Center.
A personalized lung cancer risk assessment, combining a blood test based on a four-marker protein panel developed at MD Anderson and an independent model (PLCOm2012) that accounts for ...